Clinical Support Department of Shenzhen Yingchi Technology Co.,Ltd. Generalized anxiety disorder (GAD) is one of the most common disorders affecting adolescents and young adults, with prevalence rates rising significantly over the past decade. Although psychotherapy and pharmacotherapy are often effective, more than 30% of patients remain clinically unresponsive to these interventions. Additionally, patients and caregivers are... Read more
Florence, Italy, March 28, 2024 – Today, the Hanix group has announced its total acquisition of the shares of EB Neuro S.p.A. EB Neuro S.p.A. is an Italian leading manufacturer of medical devices in the neurological field with equipment for EEG, EMG, TMS and Neuronavigation. It is the first company in the world to have... Read more
Clinical Support Department of Shenzhen Yingchi Technology Co.,Ltd Professor Yan Min's team from the Department of Anesthesiology, the Second Affiliated Hospital of Zhejiang University School of Medicine, together with Associate Professor Che Xianwei's team from Hangzhou Normal University, have published their latest research results in “PAIN”, a leading journal in the field of pain. This study investigates... Read more
Clinical Support Department of Shenzhen Yingchi Technology Co.,Ltd. Repetitive transcranial magnetic stimulation (rTMS) was approved by the U.S. Food and Drug Administration (FDA) in 2008 for the treatment of major depression that is refractory to multiple medications. The initial treatment time of rTMS protocol is about 45 minutes, once a day for 20-30 days. This treatment... Read more
Date/Time:Tuesday, March 5th, 2024 - Wednesday, March 6th, 2024 Location:Shenzhen, Guangdong, China In order to expend the distributors' knowledge of TMS and more understanding of YINGCHI TMS device, so as to deal with and solve related problems more effectively, and to consolidate the friendly cooperative relationship with our partners, our company held the 2024 Asia Business Partner... Read more
Clinical Support Department of Shenzhen Yingchi Technology Co.,Ltd. Stanford Neuromodulation Therapy (SNT) is an accelerated, high-dose iTBS treatment regimen guided by resting-state functional MRI (FCMRI), and is currently approved by the US FDA for the treatment of major depression ( MDD). Compared with current conventional depression treatments, this therapy is more effective, faster-acting, and has... Read more
